Supplier
Shanghai Bocimed Pharmaceutical Co., Ltd.
| Address: | Songtao Road #647, building 1 |
| ZIP and City: | Shanghai |
| Country: | China |
| Website: | http://www.bocimed.com/ |
| Sales Contact: | |
| Name: | Ricky Fang |
| Phone: | +86 13023978308 |
Company Description:
Shanghai Bocimed Pharmaceutical Co., Ltd. (Bocimed) was established in Shanghai Zhangjiang Pharma Valley in 2012. Having two internal R&D centers settled in Shanghai and Nanjing, and a subsidiary clinical company in Chengdu, Bocimed now established an efficient R&D team with about 200 staffs and possesses specialized R&D equipments worth more 40 million RMB. Our comprehensive R&D platform mainly focuses upon small molecule innovative drugs, modified innovative drugs, highly difficult pharmaceutical preparations, DMF&MAH and clinical research, committing to provide global pharmaceutical companies with extremely competitive drug and create international and frontier pharmaceutical R&D and innovative platform.
Bocimed has more than 100 product development technologies, focusing on various therapeutic areas including oncology, cardiovascular science, immunology, neurological and mental health. With well-established internal intellectual property system,we have 16 authorized and 47 pending approval patents up to now.
Brivaracetam
| CEP Status: | |
| CEP Number: | |
| CEP Issue Date: | |
| GMP: |  |
| DMF: | |
More API's of Shanghai Bocimed Pharmaceutical Co., Ltd.
Click here for complete listDisclaimer:
Our company does not sell compounds that are covered by patents. According to the relevant provisions of the Patent Law, the act of importing, manufacturing or using a patented drug without the consent of the patentee for testing to obtain data and other information required by the drug administration before the expiration of the patent is deemed not to infringe the patent.